What we do Syncom Formulations (India) Ltd is an Indian pharmaceutical company manufacturing over 200 formulations including tablets, capsules, injectables, and herbal products, serving domestic and international markets. |
Founded in 1,988 |
Market share Notable player in Indian pharma with strong manufacturing and export presence, especially in generic and ethical segments. |
Problem solved Provides affordable, high-quality pharmaceutical drugs and healthcare products addressing acute and chronic medical needs globally. |
Top clients or who we serve Serves hospitals, healthcare providers, and retail consumers across India and exports to Africa and Asia; B2B and B2C. |
Key management Shri Kedarmal Shankarlal Bankda (Chairman & Whole-time Director), Shri Vijay Shankarlal Bankda (Managing Director) |
Our journey and innovations Founded 1988; expanded manufacturing in 1990s; diversified into ethical prescription drugs; recent capacity expansions enhance injectable production. |
Where we operate India, Africa (Guinea, Ghana, Kenya, Tanzania, Nigeria), Asia (Azerbaijan, Nepal, Sri Lanka) |
Top products or what we offer Pharmaceutical formulations including tablets, capsules, injectables, ointments, herbal products, and OTC medicines. |
Top brands Edicare, Attom Megacaps, Ecziguard, Yas Antacid - key herbal and healthcare brands |
Raw materials needed Active Pharmaceutical Ingredients (APIs), excipients, packaging materials |
Raw materials supplier Domestic and international suppliers; significant API imports from China |
Recurring vs cyclical contribution Majority revenue is recurring through steady pharmaceutical sales with some cyclical export fluctuations |
Our industry position Among top 1000 listed Indian pharma companies with growing export footprint and diverse product portfolio |
Financial highlights FY 2024-25 Revenue Rs.460 Cr, Net Profit Rs.49 Cr, EBITDA Rs.70 Cr; strong growth over prior year |
Geographical revenue split India ~15%, Outside India ~85% exports primarily to Africa and Asia |
Order book - |
Whats driving growth Capacity expansion, product diversification, export demand, increasing chronic and OTC therapy needs |
Our future plans Enhance injectable capacity, enter nutraceuticals and wellness products, expand global market reach |
Our green promise - |
Our people and values Over 1000 employees with focus on talent development, gender equality, and safe workplace practices |
Key challenges ahead Global tariff risks, supply chain costs, regulatory price controls, and heavy API import dependence |
Interesting facts Exports doubled in late 1990s; renewed focus on herbal product line with established brands |
Risks and strategy Mitigating tariff and supply risks through diversification, cost control, and compliance; expanding product portfolio for resilience |
